Cost Legitimacy Verification Prices Too Low (Red Flags): Under $299/month: Question medication source Research chemicals: Not pharmaceutical-grade Overseas suppliers: Illegal, unregulated No prescription required: Illegal Prices Too High (Questions to Ask): Over $650/month: What justifies premium
PUSH/PULL/OFF/PUSH/LEGS/PULL/OFF *Everything is one top set of 5-7 reps Push A Reverse Banded Low Incline Smith Incline Chest Press (Lifefitness) Flat Converging Press Roller fly Lying cuff laterals Crossbody extension Seated extension Pull A SLDL Barbell row Neutral grip chest supported row for upper back Neutral grip pulldown Low cable row for lats Reverse peck deck Preacher curls Incline db curl or step away curl just for stretch position PUSH B Crucifix laterals Plate loaded shoulder press machine Reverse banded high incline smith Low ncline close grip smith Standing cable laterals Dual rope pushdown Bent over rope extensions LEGS Lying hams ( have no acsess to good seated hams machine) Smith squat ( have no acsess more stable environment for a squat pattern) Leg press Leg extension Adductor Calf Pull B Dual rope pullover/Single arm cuff pullover (I use one or another) One arm kneeling pulldown for lats Standing iso row for lats Pronated grip chest supported row Bent over row(if lower back is fine, otherwise teres pulldown will be my choice) Posterior delt cable fly Seated db curl Hammer curl Do you think that these kind of volume approach just warm ups,feeders and 1 all out set to failure is not optimal due to the dose-response relationship
Examples from the alert include: Certificates of analysis (COAs) for the last ten lots (or all lots if fewer) and an example COA that would accompany each lot
In the SURMOUNT3 trial, individuals who received tirzepatide after a comprehensive 12week lifestyle intervention achieved a mean 25% weight reduction, compared to 4.8% in the placebo group [178], suggesting a benefit for staged lifestyle intervention with GLP1s
These relationships may inform clinical decision-making in situations where treatment switching is required as a result of availability, cost, or tolerability considerations
